Tumor suppressors play an important role in cancer pathogenesis and in the modulation of resistance to treatments. Loss of function of the proteins encoded by tumor suppressors, through genomic inactivation of the gene, disable all the controls that balance growth, survival, and apoptosis, promoting cancer transformation. Parallel to genetic impairments, tumor suppressor products may also be functionally inactivated in the absence of mutations/deletions upon post-transcriptional and post-translational modifications. Because restoring tumor suppressor functions remains the most effective and selective approach to induce apoptosis in cancer, the dissection of mechanisms of tumor suppressor inactivation is advisable in order to further augment targeted strategies. This review will summarize the role of tumor suppressors in chronic lymphocytic leukemia and attempt to describe how tumor suppressors can represent new hopes in our arsenal against chronic lymphocytic leukemia (CLL).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139490PMC
http://dx.doi.org/10.3390/cancers12030629DOI Listing

Publication Analysis

Top Keywords

tumor suppressors
20
chronic lymphocytic
12
lymphocytic leukemia
12
tumor suppressor
12
tumor
8
suppressors chronic
8
leukemia lost
4
lost partners
4
partners active
4
active targets
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!